Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Elranatamab-bcmm (e.g., Elrexfio) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Elotuzumab (e.g., Empliciti) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Elivaldogene autotemcel (e.g., Skysona) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Electrostimulation and Electromagnetic Therapy for the Treatment of Wounds | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Electrophrenic Pacemaker (Diaphragmatic Pacemaker) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Electronic Brachytherapy for Nonmelanoma Skin Cancer | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Electromagnetic Navigation Bronchoscopy | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Electrical and/or Magnetic Stimulation, Pelvic Floor Muscles-Adult Urinary and Fecal Incontinence | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Electric Breast Pump (Hospital Grade) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Electrical/Electromagnetic Stimulation for the Treatment of Arthritis | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Electrical Stimulation, Occipital and Transcutaneous Peripheral Nerve Stimulation for Treatment of Headaches | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Electrical Stimulation, Deep Brain (e.g. Parkinsonism, Dystonia, Multiple Sclerosis, Post-Traumatic Dyskinesia) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Electrical Stimulation, Baroreflex Stimulation for the Treatment of Hypertension | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Electrical Stimulation, Auricular Stimulation and Cranial Electrotherapy Stimulation | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Elapegademase-lvlr (e.g., Revcovi) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Eladocagene Exuparvovec (e.g., Kebilidi) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | EKG, Signal Averaged | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Efgartigimod alfa and Hyaluronidase-qvfc (e.g., Vyvgart Hytrulo) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Efgartigimod (e.g., Vyvgart) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Edaravone (e.g., Radicava) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Eculizumab (e.g., Soliris) and Biosimilars | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Dynamic Spinal Visualization and Vertebral Motion Analysis | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Durvalumab (e.g., Imfinzi) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Dry Needling (e.g., Myofascial Trigger Points) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Dostarlimab (e.g., Jemperli) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Dopamine Transporter Imaging with Single Photon Emission Computed Tomography (DAT-SPECT) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Donanemab (e.g., Kisunla) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Discectomy: Percutaneous and Percutaneous Endoscopic, Manual, Automated or Laser | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Digital Motion X-ray (Cineradiography/Videoradiography) for Musculoskeletal Conditions | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Digital Imaging for the Detection of Diabetic Retinopathy | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Digital Health Therapies for Substance Abuse | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Digital Health Therapies for Attention Deficit/Hyperactivity Disorder | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Digital Health Technologies: Therapeutic Applications | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Digital Health Technologies: Diagnostic Applications | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Difelikefalin (e.g., Korsuva) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Dexmedetomidine (e.g., Igalmi) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Dexamethasone intraocular suspension (e.g., DEXYCU) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Denosumab ( e.g., Xgeva and Prolia) and Biosimilars | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Denileukin diftitox-cxdl (e.g., Lymphir) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Delandistrogene moxeparvovec-rokl (e.g., Elevidys) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Implantable, Subcutaneous, Extravascular, and Wearable (VEST) Cardioverter Defibrillators and Automated External Defibrillators (AED) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Datopotamab deruxtecan-dlnk (e.g., Datroway) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Daratumumab (e.g., Darzalex) / Daratumumab and Hyaluronidase-fihj (e.g., Darzalex Faspro) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Patient-Specific Instrumentation (eg Cutting Guides) for Joint Arthroplasty | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Whole Gland Cryosurgical Ablation of Prostate Cancer | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Cryosurgical Ablation of Primary or Metastatic Liver Tumors | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Cryoablation, Radiofrequency Ablation and Laser Ablation for Treatment of Chronic Rhinitis | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Cryoablation of Neoplastic Conditions | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Crovalimab-akkz (e.g., PiaSky) | New policy |